Indus Gene is a contract manufacturing organisation focused on mAb vaccines, lipid mediators and other bio-pharmaceuticals with an aim to become world leader in this niche market. Dr. C. Channa Reddy is the founder of Indus Gene Expressions Ltd.. After working for over 40 years in USA, he returned to India in 2013 to startup Indus Gene. He has been a distinguished professor at Penn State University, USA, for over 38 Years. He is internationally recognized for his research contributions on prostaglandins and leukotrienes, compounds that are involved in the pathophysiology of many diseases. Therefore, Indus Gene is well placed to monopolize the Eicosanoid market.